The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen

Fertil Steril. 2011 Jun 30;95(8):2642-4. doi: 10.1016/j.fertnstert.2011.01.035. Epub 2011 Feb 5.

Abstract

In an attempt to evaluate the role of inositol supplementation in insulin-resistant patients with polycystic ovary syndrome (PCOS), undergoing gonadotropin ovulation induction using the low-dose step-down regimen, we conducted a prospective longitudinal study comparing the stimulation characteristics of 15 patients treated with inositol, to a cohort, matched by age and body mass index (BMI), without inositol. Inositol nutritional supplementation produced very good clinical results with a significant reduction in cancellation rate (0 vs. 40%) and the consequent improvement in clinical pregnancy rate (PR) (33.3% vs. 13.3%).

MeSH terms

  • Adult
  • Case-Control Studies
  • Chi-Square Distribution
  • Dietary Supplements*
  • Female
  • Fertility Agents, Female / administration & dosage*
  • Gonadotropins / administration & dosage*
  • Humans
  • Infertility, Female / etiology
  • Infertility, Female / physiopathology
  • Infertility, Female / therapy*
  • Inositol / administration & dosage*
  • Insulin Resistance*
  • Italy
  • Longitudinal Studies
  • Ovulation / drug effects
  • Ovulation Induction / methods*
  • Pilot Projects
  • Polycystic Ovary Syndrome / complications
  • Polycystic Ovary Syndrome / drug therapy*
  • Polycystic Ovary Syndrome / physiopathology
  • Pregnancy
  • Pregnancy Rate
  • Prospective Studies
  • Treatment Outcome

Substances

  • Fertility Agents, Female
  • Gonadotropins
  • Inositol